To provide an integrated offer for the preclinical development of biotherapeutics, GTP has added mammalian cell line development services to its portfolio. We can now supply a CHO stable cell line ready for transfer to GMP manufacturing.
Published on 2018-10-19 Upstream Process
The GTP team has developed CHO-based transient transfection services using an optimized in-house protocol for timely production of recombinant proteins
Published on 2018-09-04 Process development
Advice from GTP’s experts to help you define and develop the best process for your recombinant protein and antibody project.
Published on 2018-07-17 Quality control
GTP's BSO assists technical leaders, assesses risks and is key to the implementation and continued application of a full-fledged biosafety policy.
Published on 2018-04-05 Upstream Process
Recent advances in mammalian cell line development and discussion of the criteria a biotech company should consider when starting its cell line development process.
Published on 2018-02-08 Protein engineering
What is antibody humanisation and what are the main differences between chimeric, humanised and fully human antibodies? An overview of what we learned from our discussions with Olivier Léger, an expert in antibody engineering with over 25 years' experience in the field.
Published on 2017-10-02 Upstream Process
A hint: it's not only about science.
Published on 2017-06-12 Downstream Process
Why membrane chromatography may be beneficial to your protein purification process. Why and where you should use membrane chromatography.
Published on 2017-05-12 Downstream Process
Why integration of continuous chromatography could help the biopharma industry overcome the challenge of increasing capacities while decreasing manufacturing costs.
Published on 2017-03-30 Quality control
The best way for biotech companies to address the analytical development of their biotherapeutic candidates at preclinical and clinical stages.